title: Immune reconstitution: bad or good factor in hepatitis B virus and HIV co-infection?
authors.forename: Oreste
authors.initials: O
authors.lastname: Perrella
authors.forename: Costanza
authors.initials: C
authors.lastname: Sbreglia
authors.forename: Raffaele
authors.initials: R
authors.lastname: De Sena
authors.forename: Anna
authors.initials: A
authors.lastname: D'Antonio
authors.forename: Marco
authors.initials: M
authors.lastname: Perrella
authors.forename: Oreste
authors.initials: O
authors.lastname: Cuomo
authors.forename: Alessandro
authors.initials: A
authors.lastname: Perrella
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D000998:Antiviral Agents / Q000627:therapeutic use*; D018450:Disease Progression; D015658:HIV Infections / Q000150:complications* / Q000276:immunology; D015497:HIV-1; D006509:Hepatitis B / Q000150:complications* / Q000276:immunology; D006515:Hepatitis B virus; D006801:Humans
chemical_list: D000998:Antiviral Agents